USARIEM
Welcome,         Profile    Billing    Logout  
 4 Trials 
2 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Smith
BROOKLYN, NCT05425745 / 2021-005064-22: Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

Completed
3
354
Europe, Canada, US, RoW
Obicetrapib, CETP-inhibitor, Placebo
NewAmsterdam Pharma
Dyslipidemias, High Cholesterol, Hypercholesterolemia, Familial Hypercholesterolemia, Lipid Metabolism Disorder, Metabolic Disease, Lipid Metabolism, Inborn Errors, Genetic Disease, Inborn, Hyperlipoproteinemias
05/24
05/24
NalPORS, NCT05072249: European Cohort Study of the Effectiveness of Take Home Naloxone

Recruiting
N/A
6000
Europe
Naloxone, Prenoxad, Nyxoid, Ventizolve
King's College London, Mundipharma Research Limited
Opioid Overdose
12/23
12/23
Ryan, Benjamin J
No trials found
Salgado, Roy M
No trials found
Seeley, Afton D
No trials found

Download Options